Inventiva S.A. - Ordinary shares, nominal value 0.01 EUR per share (IVA)

CUSIP: 46124U107

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 6 signals
Share change
+5,651,086
SEC-reported price per share
$5.55
Number of holders
65
Value change
+$33,011,012
Number of buys
44
Number of sells
20
Security identity 1 source field
Shares outstanding
207,459,176

Security key

46124U107

Report period

Q1 2026

Institutions

65

Top holders

10

Ownership snapshot

Top reported holders of IVA - Inventiva S.A. - Ordinary shares, nominal value 0.01 EUR per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Invus Global Management, LLC
Disclosed value leader
Sofinnova Crossover I
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 13F Lead comparable stake: 11% 13D/G row: Invus Global Management, LLC Showing 1-6 of 15 holder rows.

Quick read

Invus Global Management, LLC leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Comparable ownership Top 5
Invus Global Management, LLC 11%
Sofinnova Crossover I 8.6%
Andera Partners 7.7%
Samsara BioCapital, L.P. 7.4%
Yiheng Capital Management, L.P. 5.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Invus Global Management, LLC
13D/G
Invus Public Equities, L.P.
11%
$49,037,031
14,814,813 shares
+$24,518,517 30 Jun 2025
Sofinnova Crossover I
13D/G
Sofinnova Partners SAS, a French corporation
8.6%
$108,981,346
19,086,050 shares
+$64,487,273 31 Dec 2025
Andera Partners
13D/G 13F
Company
7.7%
$80,593,658
14,114,476 shares
+$10,381,814 31 Dec 2025
Samsara BioCapital, L.P.
13D/G
Srinivas Akkaraju
7.4%
$56,191,805
13,540,194 shares
+$22,319,746 17 Nov 2025
Yiheng Capital Management, L.P.
13D/G 13F
Yiheng Capital Partners, L.P. · Company
5.5%
$43,962,416
7,597,148 shares
+$18,899,084 30 Sep 2025
PERCEPTIVE ADVISORS LLC
13D/G
5%
$42,246,764
7,300,666 shares
+$10,098,434 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
65
Shares
52,342,519
Rows available
65
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
53
Q1 2026 holders
65
Holder diff
12
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .